Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase III landiolol for intraoperative tachyarrhythmia under general anesthesia
ChiCTR2500113077Phase 3Not yet recruiting
- Sponsor
- Third Xiangya Hospital, Central South University
- Start
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in tachyarrhythmia comparing Landiolol arm with Placebo arm (2 arms). Primary endpoint: Proportion of patients with effective control of tachycardia at 11 minutes after start of dosing. Planned start Nov 2025; status: not yet recruiting.
02
Drugs
landiolol
03
Conditions
tachyarrhythmia
Beyond the preview
Go deeper on ChiCTR2500113077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500113077.